Form D · Biotechnology
NextCure, Inc.
Beltsville, MD · CIK 0001661059
Offering snapshot reported Dec 10, 2025 · SEC filing
- Reported sold
- $21.5M Offering amount: $21.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 12, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2025 | Initial | $21,500,000 | No comparison | 12 | SEC filing |
| Nov 19, 2018 | Initial | $93,432,873 | No comparison | 22 | SEC filing |
| Jan 11, 2016 | Initial | $15,000,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $1.22M
- Form D file number
- 021-566324
The placement agent received at closing a cash fee equal to a percentage of the aggregate consideration plus certain expenses.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 000000375 |
Source: Form D, filed Dec 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anne Borgman | Director |
| Steven P. Cobourn | Executive |
| Ellen G. Feigal | Director |
| Carolyn Green | Director |
| Udayan Guha | Executive |
| Kevin N. Heller | Executive |
| John G. Houston | Director |
| Elaine V. Jones | Director |
| David Kabakoff | Director |
| Chau Q. Khuong | Director |
| Sourav Kundu | Executive |
| Judith Li | Director |
| Timothy Mayer | Executive |
| Michael Richman | Director, Executive |
| Asher Rubin | Executive |
| Tim Shannon | Director |
| Kevin Shaw | Executive |
| Stephen Webster | Director |
| Stella Xu | Director |
| Michael Yi | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9000 Virginia Manor Road Suite 200
Beltsville, MD, 20705
Beltsville, MD, 20705